Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Clinical Trial

Comparative Study

Meta-Analysis

Research Support, N.I.H., Extramural

Multicenter Study

Publication Year

From

Quick links

Individual year

2017

2014

2013

2011

2009

2006

2002

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Lipoproteins, HDL2""[mesh_terms]

7 Results

Searching titles within these results

Chemical modification of high density lipoprotein subfractions - HDL2 and HDL3 - after use of atorvastatin.

Vanessa Helena de Souza Zago, José Eduardo Tanus-Santos, Mirian Regina Gardin Danelon, Eliane Soler Parra, Fernanda Alexandre, Isabela Calanca Vieira, Natália Baratella Panzoldo, Fábio Luís D'Alexandri, Eder Carlos Rocha Quintão, Eliana Cotta de Faria

International journal of clinical pharmacology and therapeutics 2014;52(4):277-83

Full Text

Abstract

Aerobic exercise and HDL2-C: a meta-analysis of randomized controlled trials.

K S Kelley, George A Kelley

Atherosclerosis 2006;184(1):207-15

Free Full Text

Abstract

α-Tocopherol induces proatherogenic changes to HDL2 & HDL3: an in vitro and ex vivo investigation.

Ann McGinty, Jayne V Woodside, Jane McEneny, Cyril McMaster, Lauren Wade, Nida Nadeem, Ian S Young

Atherosclerosis 2013;226(2):392-7

Full Text

Abstract

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.

Tomoyasu Fukui, Toshiyuki Hayashi, Noriko Nakanishi, Saki Yamamoto, Masako Tomoyasu, Anna Osamura, Makoto Ohara, Takeshi Yamamoto, Yasuki Ito, Tsutomu Hirano

Cardiovascular diabetology 2017;16(1):8

Free Full Text

Abstract

Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.

J H J M Meuwissen, L Beijers-De Bie, T Vihtamaki, R Tuimala, N Siseles, C Magaril, H S The, P W H Houben, M Murga, D Spielmann, T J De Villiers

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2002;16(2):155-62

Full Text

Abstract

Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia.

Zélie Julia, Emilie Duchene, Natalie Fournier, Natacha Bellanger, M John Chapman, Wilfried Le Goff, Maryse Guerin

Journal of lipid research 2011;51(11):3350-8

Free Full Text

Abstract

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia.

C S Derdemezis, T D Filippatos, E S Nakou, D P Mikhailidis, A D Tselepis, D N Kiortsis, M S Elisaf

Expert opinion on pharmacotherapy 2009;9(18):3151-8

Full Text

Abstract

Results: 1 – 7 / 7

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Lipoproteins, HDL2""[mesh_terms]

Chemical modification of high density lipoprotein subfractions - HDL2 and HDL3 - after use of atorvastatin.

Aerobic exercise and HDL2-C: a meta-analysis of randomized controlled trials.

α-Tocopherol induces proatherogenic changes to HDL2 & HDL3: an in vitro and ex vivo investigation.

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.

Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.

Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia.

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia.

Results for
""Lipoproteins, HDL2""[mesh_terms]